RT Journal Article
SR Electronic
T1 Vitamin D status in chronic tic-disorder and comorbid obsessive-compulsive disorder and attention-deficit/hyperactivity disorder: A pan-European study
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 19012062
DO 10.1101/19012062
A1 Bond, Molly
A1 Moll, Natalie
A1 Rosello, Alicia
A1 Bond, Rod
A1 Schnell, Jaana
A1 Burger, Bianka
A1 Hoekstra, Pieter J.
A1 Dietrich, Andrea
A1 Schrag, Anette
A1 Kocovska, Eva
A1 Martino, Davide
A1 Mueller, Norbert
A1 Schwarz, Markus
A1 Meier, Ute-Christiane
A1 the EMTICS collaborative group
YR 2019
UL http://medrxiv.org/content/early/2019/12/04/19012062.abstract
AB Background Hypovitaminosis-D has been linked to neuropsychiatric conditions, but little is known about vitamin D status in individuals with chronic tic disorders (CTD). This study sought to determine whether vitamin D levels are associated with the severity of tics and presence and severity of comorbid obsessive-compulsive disorder (OCD) and/ or attention-deficit/hyperactivity disorder (ADHD).Methods This is a cross-sectional sub-study of the European Multicentre Tics in Children Studies (EMTICS). Vitamin D [25(OH)D] levels (ng/ml) were obtained for 327 participants with CTD at study entry and tic severity was measured using the Yale Global Tic Severity Scale (YGTSS). An association between tic severity and presence and severity of comorbid OCD and/or ADHD symptoms was analysed using multilevel models controlling for season, site, sex, age and presence of comorbid OCD and/or ADHD.Results The participants comprised 247 boys and 80 girls (4-16 years, mean [SD], 10.9 [2.72]). Hypovitaminosis-D ([25(OH)D] < 20ng/ml) was present in 33% of participants with CTD and/ or comorbid OCD and/ or ADHD. The authors found no association between 25(OH)D levels and tic severity or OCD symptom severity. However, lower 25(OH)D levels were significantly associated with increased severity of ADHD symptoms in participants with CTD (β = -0.25, s.e. = 0.08, 95% CI, -0.42 to -0.09; p < 0.01).Conclusion Additional research is needed to confirm these findings and assess whether hypovitaminosis-D may represent an underlying biological vulnerability for comorbid ADHD symptoms in CTD as it may signpost novel strategies for prevention and treatment.Competing Interest StatementDr Meier filed a patent “Biomarkers for inflammatory response”. All other authors reported no biomedical financial interest or potential conflict of interest.Funding StatementThis project has received funding from the European Union's Seventh Framework Programme for research, technological development and demonstration under grant agreement no 278367.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data can be obtained from the authors